Characterisation of hyaluronic acid and chondroitin/dermatan sulfate from the lumpsucker fish, C. lumpus

被引:22
|
作者
Panagos, Charalampos G. [1 ]
Thomson, Derek [2 ]
Moss, Claire [2 ]
Bavington, Charles D. [2 ]
Olafsson, Halldor G. [3 ]
Uhrin, Dusan [1 ]
机构
[1] EaStCHEM Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
[2] GlycoMar Ltd, European Ctr Marine Biotechnol, Oban PA37 1QA, Argyll, Scotland
[3] Biopol, IS-545 Skagastrond, Iceland
基金
英国工程与自然科学研究理事会;
关键词
Cyclopterus lumpus; Chondroitin sulfate; Dermatan sulfate; Hyaluronic acid; Glycosaminoglycan; NMR; MASS-SPECTROMETRIC ANALYSIS; DERMATAN SULFATE; SEA-CUCUMBER; STRUCTURAL-CHARACTERIZATION; ANTIINFLAMMATORY ACTIVITY; ANTICOAGULANT ACTIVITIES; MARINE-INVERTEBRATES; PROTEIN INTERACTIONS; CONNECTIVE-TISSUE; HEPARAN-SULFATE;
D O I
10.1016/j.carbpol.2014.01.090
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The lumpsucker, Cyclopterus lumpus, a cottoid teleost fish found in the cold waters of the North Atlantic, and North Pacific, was identified as a possible source of GAGs. The GAGs present in the C. lumpus dorsal hump and body wall tissue were isolated and purified. Two fractions were analysed by NMR and their GAG structures determined as hyaluronic acid and CS/DS chains. The latter fraction contained GIcA (65% of the total uronic acids) and IdoA (the remaining 35%). All uronic acid residues were unsulfated, whilst 86% of the GalNAc was 4-sulfated and 14% was 6-sulfated. The presence of GlcA-GalNAc4S, IdoA-GalNAc4S and GlcA-GalNAc6S disaccharide fragments was confirmed. The isolated GAGs obtained from each tissue were biochemically characterised. The lumpsucker offers a high yield source of GAGs, which compares favourably with other sources such as shark cartilage. (c) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 50 条
  • [41] HYALURONIC-ACID AND DERMATAN SULFATE IN LESIONAL AND NONLESIONAL PSEUDOXANTHOMA ELASTICUM SKIN
    LEBWOHL, M
    PHELPS, R
    LEMLICH, G
    PALAIA, M
    LONGAS, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 86 (04) : 487 - 487
  • [42] HYALURONIC-ACID AND DERMATAN SULFATE IN LESIONAL AND NONLESIONAL PSEUDOXANTHOMA ELASTICUM SKIN
    LEBWOHL, M
    PHELPS, R
    LEMLICH, G
    PALAIA, M
    LONGAS, M
    CLINICAL RESEARCH, 1986, 34 (02): : A762 - A762
  • [43] IDENTIFICATION OF THE URONIC ACID COMPONENT OF DERMATAN SULFATE (BETA-HEPARIN, CHONDROITIN SULFATE-B)
    STOFFYN, PJ
    JEANLOZ, RW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1960, 235 (09) : 2507 - 2510
  • [44] EVIDENCE FOR STRUCTURAL-CHANGES IN DERMATAN SULFATE AND HYALURONIC-ACID WITH AGING
    LONGAS, MO
    RUSSELL, CS
    HE, XY
    CARBOHYDRATE RESEARCH, 1987, 159 (01) : 127 - 136
  • [45] Proteomic Analysis of Potential Keratan Sulfate, Chondroitin Sulfate A, and Hyaluronic Acid Molecular Interactions
    Conrad, Abigail H.
    Zhang, Yuntao
    Tasheva, Elena S.
    Conrad, Gary W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (09) : 4500 - 4515
  • [46] Proteomic Analysis of Potential Keratan Sulfate, Chondroitin Sulfate A, and Hyaluronic Acid Molecular Interactions
    Conrad, A. H.
    Zhang, Y.
    Tasheva, E. S.
    Conrad, G. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [47] ORGANIZATION OF GLYCOSAMINOGLYCAN CHAINS IN A CHONDROITIN SULFATE-DERMATAN SULFATE PROTEOGLYCAN FROM BOVINE AORTA
    RADHAKRISHNAMURTHY, B
    JEANSONNE, N
    BERENSON, GS
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 882 (01) : 85 - 96
  • [48] A coarse-grained molecular model for glycosaminoglycans: Application to chondroitin, chondroitin sulfate, and hyaluronic acid
    Bathe, M
    Rutledge, GC
    Grodzinsky, AJ
    Tidor, B
    BIOPHYSICAL JOURNAL, 2005, 88 (06) : 3870 - 3887
  • [49] GLYCOSAMINOGLYCAN STIMULATION OF CALCIUM RELEASE FROM MOUSE CALVARIAE - SPECIFICITY FOR HYALURONIC-ACID AND DERMATAN SULFATE
    COCHRAN, DL
    CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (02) : 79 - 85
  • [50] Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems
    Fernandez-Pineiro, I.
    Pensado, A.
    Badiola, I.
    Sanchez, A.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 125 : 85 - 94